Epidiolex
GW Pharmaceuticals Releases a Q4 Revenue Beat, but Will the Rapid Growth Continue?
Bottom Line Cannabinoid prescription medicine company GW Pharmaceuticals (NASDAQ: GWPH) pre-announced revenues for its fourth quarter and full-year last night.…
Britain’s First Cannabis-Based Medicine Will Be Available in January
Epidyolex will be available for British epilepsy sufferers from Jan. 6 after the government fast-tracked it into the National Health…
Britain Approves First Two Medical Cannabis Products
British campaigners are celebrating an important milestone after the NHS approved its first two medical cannabis products. New guidance from…